PC-300 Tea Effect on Triglyceride Levels
Palabras clave
Abstracto
Descripción
It was a descriptive, prospective, longitudinal, and comparative clinical study developed at Ciprés Grupo Médico S.C. (CGM), Toluca, Mexico, from January 2014 to December 2014.
Patients with hypertriglyceridemia were invited to participate in the study. Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating.
Patients were measured (m) and weighed (kg) (Obi, México). Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Blood pressure was measured with a calibrated sphygmomanometer (Welch Allyn, USA) after 5 min of rest.
All of the patients were given a low lipid diet. Calculated kcal were based on ideal weight minus 200 kcal/day if overweight.
Results were expressed as mean ± Standard deviation (SD). Differences between initial vs. final values were compared with the Mann-Whitney U test. The normality hypothesis was tested using the Kolmogorov-Smirnov test. A p value of <0.05 was considered significant. All tests were performed with the SPSS ver. 23 statistical software program.
fechas
| Verificado por última vez: | 07/31/2018 |
| Primero enviado: | 08/23/2018 |
| Inscripción estimada enviada: | 08/26/2018 |
| Publicado por primera vez: | 08/27/2018 |
| Última actualización enviada: | 08/26/2018 |
| Última actualización publicada: | 08/27/2018 |
| Fecha de inicio real del estudio: | 12/31/2013 |
| Fecha estimada de finalización primaria: | 11/29/2014 |
| Fecha estimada de finalización del estudio: | 12/30/2014 |
Condición o enfermedad
Intervención / tratamiento
Dietary Supplement: PC-300 tea
Drug: Bezafibrate
Fase
Grupos de brazos
| Brazo | Intervención / tratamiento |
|---|---|
| Experimental: PC-300 tea Patients that received the Eryngium heterophyllum + Amphipterygium adstringens tea, one cup half an hour before eating. | Dietary Supplement: PC-300 tea Patients had to drink one cup of the tea half an hour before breakfast, main meal and dinner. |
| Active Comparator: Bezafibrate Patients that received fibrate (bezafibrate) 200 mg/day. | Drug: Bezafibrate Patients were prescribed 200 mg/day at night. |
Criterio de elegibilidad
| Edades elegibles para estudiar | 18 Years A 18 Years |
| Sexos elegibles para estudiar | All |
| Acepta voluntarios saludables | si |
| Criterios | Inclusion Criteria: - Patients with hypertriglyceridemia, aged >18 years and with an educational level at least of primary school. Exclusion Criteria: - Patients with hepatic disease and those missing an appointment during the study. |
Salir
Medidas de resultado primarias
1. Triglycerides serum levels. [One month.]
